The previous two papers in this series described the properties of the
FMD virus, the epidemiological picture up to 1986 and the consequence
s of the introduction of the obligatory countrywide vaccination progra
mme. This paper describes how a change in strategy was achieved. An ex
amination of the time course of vaccination and outbreak of FMD sugges
ted a causal association. The primary cause appeared to be the vaccine
itself, but escape of the virus from vaccine production plants also o
ccurred. The latter was confirmed by molecular genetic examination of
the viruses. A cost-benefit study conducted European Union (EU) reveal
ed that routine nation-wide vaccination was not the most beneficial op
tion. As a result from 1 January 1992 the EU prohibited the use of rou
tine vaccination in member countries. Subsequently, molecular genetic
studies of viruses indicated that outbreaks in Turkey and the Near Eas
t present the greatest risk for the introduction of FMDV into the Euro
pean Union.